Proteomics Advances in Parkinson's Disease Research Highlighted in New Collection
A new collection of studies is showcasing the transformative role of proteomics in understanding Parkinson's disease (PD). This collection emphasizes the use of advanced proteomic tools, such as mass spectrometry and spatial profiling, to uncover the complex protein networks involved in neurodegeneration. The focus is on mapping cell-type-specific and spatially resolved proteomes, characterizing post-translational modifications, and integrating proteomics with multi-omics datasets. These studies aim to identify biomarkers, therapeutic targets, and innovative methodologies that could accelerate the development of precision medicine for PD. The collection invites contributions that explore proteome-wide changes in various biological samples, including brain, cerebrospinal fluid (CSF), and plasma, and highlights the potential of proteomics to reshape our understanding of PD biology.